Education
About Us
Working with TipRanks
Follow Us
Andrew Schwab Insider Profile
4 Followers
Andrew Schwab, Director, Ten Percent Owner at Flexion Therapeutics, holds 2.63M shares in CAMP4 Therapeutics Corporation (Ticker: CAMP), holds 9.91M shares in Skye Bioscience (Ticker: SKYE), holds 960.38K shares in Enliven Therapeutics (Ticker: ELVN).
Andrew Schwab Flexion Therapeutics (~FLXN)Director, Ten Percent Owner
Flexion Therapeutics (~FLXN)
Director, Ten Percent Owner
Ranked #60,739 out of 102,674 Corporate Insiders
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
-5.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Andrew Schwab holds in companies
Most Profitable Insider Trade
Stock:
Flexion Therapeutics
(~FLXN)
(~FLXN)
Rating:Informative Buy
Date:Feb 11, 2014 - Feb 11, 2015
Return:+57.30%
The most profitable trade made by Andrew Schwab
Andrew Schwab's Trading History
Flexion Therapeutics
Feb 20, 2014
―
Uninformative Buy
―
$13.79M
scPharmaceuticals
May 28, 2020
Ten Percent Owner
Informative Buy
5.00M
$19.46M
5:01 Acquisition Corp Class A
Nov 12, 2020
―
Uninformative Buy
51.26K
$3.65M
Pear Therapeutics
Dec 07, 2021
―
Uninformative Buy
2.00M
$204.95K
Enliven Therapeutics
Feb 27, 2023
Director, Ten Percent Owner
Uninformative Buy
―
$18.06M
Skye Bioscience
Sep 13, 2024
Director
Informative Sell
1.75M
$35.39M
CAMP4 Therapeutics Corporation
Oct 15, 2024
Director, Ten Percent Owner
Uninformative Buy
―
$4.28M
List of latest transactions for each holding click on a transaction to see Andrew Schwab's performance on stock
You May Also Like
Andrew Schwab insider profile FAQ
What is the percentage of profitable transactions made by Andrew Schwab?
The percentage of profitable transactions made by Andrew Schwab is 50%.
What is the average return per transaction made by Andrew Schwab?
The average return per transaction made by Andrew Schwab is -5.80%.
What stocks does Andrew Schwab hold?
Andrew Schwab holds: ~FLXN, SCPH, FVAM, PEARQ, ELVN, SKYE, CAMP stocks.
What was Andrew Schwab’s latest transaction?
Andrew Schwab latest transaction was an Uninformative Buy of ―.
What was Andrew Schwab's most profitable transaction?
Andrew Schwab’s most profitable transaction was an Informative Buy of ~FLXN stock on February 11, 2014. The return on the trade was 57.30%.
What is Andrew Schwab's role in Flexion Therapeutics?
Andrew Schwab's role in Flexion Therapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.